|
National Stock Number(NSN): 6505-00-494-8048 (6505004948048, 004948048)
| NIIN: |
00-494-8048 |
Item Name: |
AMYLASE,BILE SALT,LIPASE,PROTEASE,AND HEMICELLULASE TABLETS |
INC: |
29121
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
29121 |
| ISC: |
5 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
8 |
Cancellation Date: |
May-18-1997 |
PMIC: |
|
FIIG: |
A45000 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
FESTAL |
04500
|
HOECHST-ROUSSEL PHARMACEUTICALS INC |
H |
3 |
1 |
|
|
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
25.000 MILLIGRAMS BILE SALT ACTIVE INGREDIENT AND 50.000 MILLIGRAMS HEMICELLULASE ACTIVE INGREDIENT AND 10.000 UNITS AMYLASE ACTIVE INGREDIENT AND 10.000 UNITS LIPASE ACTIVE INGREDIENT AND 17.000 UNITS PROTEASE ACTIVE INGREDIENT |
| BLGJ |
COATING FEATURE |
FILM,ENTERIC |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQJH |
TERTIARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
500.000 TABLETS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
1 |
| CSGS |
ADMINISTRATION |
ORAL,NONCHEWABLE |
|